Cx Precision Medicine: Funding, Investors & Team (Sep 2026)
Cx Precision Medicine is a life science company developing blood-based biomarker screening technology as well as companion diagnostics for therapeutic agents. Our lead products are focused on neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and other dementia-causing disorders. Our low-cost and non-invasive tests will rule out Alzheimer’s disease and Parkinson’s disease for many and help identify others who will benefit from more comprehensive testing. Our test will also help physicians treat patients with the right medicines more quickly.
Cx Precision Medicine has raised $1.2M across 1 funding round on record, the most recent an undisclosed round of $1.2M announced in Dec 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Cx Precision Medicine Company Profile and Key Stats
Latest funding round on record: Dec 2022.
Cx Precision Medicine Funding Rounds
Cx Precision Medicine Founders and Leadership Team
No contact details are on record for this team yet.
Cx Precision Medicine Funding Compared to Other Biotechnology Startups
Cx Precision Medicine's latest round of $1.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cx Precision Medicine in Biotechnology and Fort Worth
Companies Similar to Cx Precision Medicine
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Cx Precision Medicine Funding FAQs
What does Cx Precision Medicine do?
Cx Precision Medicine is a life science company developing blood-based biomarker screening technology as well as companion diagnostics for therapeutic agents. Our lead products are focused on neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and other dementia-causing disorders. Our low-cost and non-invasive tests will rule out Alzheimer’s disease and Parkinson’s disease for many and help identify others who will benefit from more comprehensive testing. Our test will also help physicians treat patients with the right medicines more quickly.
How much funding has Cx Precision Medicine raised?
Cx Precision Medicine has raised $1.2M across 1 round on record. The most recent is an undisclosed round of $1.2M announced in Dec 2022.
When did Cx Precision Medicine last raise funding?
Cx Precision Medicine's most recent funding round on record is an undisclosed round of $1.2M, announced in Dec 2022.
Who founded Cx Precision Medicine?
FundedIQ lists Sid Obryant (Founder) at Cx Precision Medicine.
Where is Cx Precision Medicine headquartered?
Cx Precision Medicine is based in Fort Worth, Texas, United States.
How many employees does Cx Precision Medicine have?
Cx Precision Medicine is in the 1-10 employee band.
How does Cx Precision Medicine's funding compare to other Biotechnology startups?
Cx Precision Medicine's latest round of $1.2M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Cx Precision Medicine Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cx Precision Medicine is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.